{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:49:47Z","timestamp":1791560987087,"version":"4.3.4"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:p>\n                    Pilomatrix-like high-grade endometrioid carcinoma (PiMHEC) is an aggressive variant of endometrioid adenocarcinoma characterized by divergent pilomatrical differentiation. While classic cases are usually recognizable, the diagnosis can be challenging when ghost cells are rare or absent, or when encountering mimickers that share overlapping features. We investigated the utility of SOX2 immunohistochemistry as a diagnostic marker for PiMHEC. SOX2 expression was evaluated in 26 cases of PiMHEC (24 endometrial, 2 ovarian). We also analyzed problematic mimickers, including non-PiMHEC FIGO grade 3 endometrioid carcinomas (EMCA) with aberrant beta-catenin expression (n=4) and undifferentiated\/dedifferentiated EMCA (UD-EMCA) with aberrant beta-catenin expression (n=7). In addition, a tissue microarray (TMA) of 84 EMCA cases (FIGO grade 1\u20133 and UD-EMCA) was screened. All 26 PiMHEC cases (100\n                    <jats:bold>%<\/jats:bold>\n                    ) showed robust SOX2 positivity. In contrast, all non-PiMHEC FIGO grade 3 EMCAs with aberrant beta-catenin expression were negative for SOX2. While 2 of 7 UD-EMCAs with aberrant beta-catenin expression showed very focal SOX2 expression, these were easily distinguished from PiMHEC by their lack of cytokeratin expression. In the TMA cohort, only 5 of 84 cases (all FIGO grade 3) showed SOX2 positivity; these cases all had membranous beta-catenin expression, had no histologic features of PiMHEC and followed an indolent clinical course. SOX2 is a useful marker for confirming a diagnosis of PiMHEC, especially when ghost cells are inconspicuous. It effectively differentiates PiMHEC from its FIGO grade 3 mimickers with aberrant beta-catenin expression.\n                  <\/jats:p>","DOI":"10.1097\/pgp.0000000000001197","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:12Z","timestamp":1784937612000},"page":"437-446","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["SOX2 Can Support a Diagnosis of PiMHEC With Rare to Absent Ghost Cells and Can Distinguish PiMHEC From Its Most Problematic Mimickers"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0869-0507","authenticated-orcid":false,"given":"Jin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Weisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"R1-20261009","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/PGP.0000000000000775","article-title":"FIGO grade 3 endometrioid adenocarcinomas with diffusely aberrant beta-catenin expression: an aggressive subset resembling cutaneous pilomatrix carcinomas","volume":"41","author":"Weisman","year":"2022","journal-title":"Int J Gynecol Pathol"},{"key":"R2-20261009","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/PGP.0000000000000955","article-title":"An expanded series of pilomatrix-like high-grade endometrioid carcinoma (PiMHEC), including both MMR deficient and MMR proficient cases","volume":"43","author":"Xu","year":"2024","journal-title":"Int J Gynecol Pathol"},{"key":"R3-20261009","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.3390\/diagnostics12123146","article-title":"Pilomatrix-like high-grade endometrioid carcinoma of the ovary: case report, literature review, and differential diagnosis","volume":"12","author":"Santoro","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"R4-20261009","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/PGP.0000000000000859","article-title":"Pilomatrix-like high-grade endometrioid carcinoma is a morphologically and immunophenotypically distinct entity and may show mismatch repair deficiency","volume":"42","author":"Arciuolo","year":"2023","journal-title":"Int J Gynecol Pathol"},{"key":"R5-20261009","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/PAS.0000000000002402","article-title":"Pilomatrix-like high-grade endometrial carcinoma: an underdiagnosed entity with aggressive clinicopathologic features","volume":"49","author":"Zhou","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"R6-20261009","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41388-019-0997-x","article-title":"SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K\/AKT\/SOX2 axis and beyond","volume":"39","author":"Schaefer","year":"2020","journal-title":"Oncogene"},{"key":"R7-20261009","doi-asserted-by":"crossref","first-page":"100586","DOI":"10.1016\/j.modpat.2024.100586","article-title":"Wnt\/beta-catenin-activated nonpilomatrical carcinoma of the skin: a case series","volume":"37","author":"Kervarrec","year":"2024","journal-title":"Mod Pathol"},{"key":"R8-20261009","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/ajcp\/aqae132","article-title":"Correction to: pilomatrix-like breast carcinoma: a mammary analog of pilomatrix-like high-grade endometrioid carcinoma (PiMHEC)","volume":"163","author":"Xu","year":"2025","journal-title":"Am J Clin Pathol"},{"key":"R10-20261009","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.humpath.2022.03.009","article-title":"The value of SOX2 in the differential diagnosis of SMARCA4 (BRG1)-deficient uterine neoplasms","volume":"124","author":"Zheng","year":"2022","journal-title":"Hum Pathol"},{"key":"R11-20261009","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.18632\/oncotarget.26797","article-title":"Clinical validation of the tempus xT next-generation targeted oncology sequencing assay","volume":"10","author":"Beaubier","year":"2019","journal-title":"Oncotarget"},{"key":"R12-20261009","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jmoldx.2021.08.005","article-title":"Development and validation of StrataNGS, a multiplex PCR, semiconductor sequencing-based comprehensive genomic profiling test","volume":"23","author":"Tomlins","year":"2021","journal-title":"J Mol Diagn"},{"issue":"Pt 1","key":"R13-20261009","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.semcancer.2019.08.007","article-title":"SOX2 in development and cancer biology","volume":"67","author":"Novak","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"R14-20261009","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2353\/ajpath.2010.090495","article-title":"Expression of the embryonic stem cell transcription factor SOX2 in human skin: relevance to melanocyte and merkel cell biology","volume":"176","author":"Laga","year":"2010","journal-title":"Am J Pathol"},{"key":"R15-20261009","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0092-8674(01)00336-1","article-title":"Beta-catenin controls hair follicle morphogenesis and stem cell differentiation in the skin","volume":"105","author":"Huelsken","year":"2001","journal-title":"Cell"},{"key":"R16-20261009","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000490491","article-title":"Shadow cell differentiation: a comparative analysis of modes of cell death with apoptosis and epidermal\/trichilemmal keratinization","volume":"5","author":"Nakamura","year":"2018","journal-title":"Dermatopathology (Basel)"},{"key":"R17-20261009","first-page":"8189","article-title":"SOX-2, but not Oct4, is highly expressed in early-stage endometrial adenocarcinoma and is related to tumour grading","volume":"8","author":"Pitynski","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R18-20261009","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/PGP.0000000000001081","article-title":"High-grade endometrial carcinomas with solid basaloid morphology and geographic necrosis lacking definitive pilomatrix-like features: clinicopathologic characteristics including aggressive behavior and novel molecular events","volume":"44","author":"Carlson","year":"2025","journal-title":"Int J Gynecol Pathol"},{"key":"R19-20261009","doi-asserted-by":"crossref","first-page":"105928","DOI":"10.1016\/j.humpath.2025.105928","article-title":"High-grade endometrioid carcinomas with pilomatrix-like features lacking CTNNB1 mutations: clinicopathologic characteristics and novel molecular events","volume":"164","author":"Qin","year":"2025","journal-title":"Hum Pathol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PGP.0000000000001197","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:01:21Z","timestamp":1791558081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PGP.0000000000001197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000001197","relation":{},"ISSN":["0277-1691","1538-7151"],"issn-type":[{"value":"0277-1691","type":"print"},{"value":"1538-7151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"2026-02-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}